Trials / Completed
CompletedNCT00364039
Study to Examine the Safety, Tolerability, and Pharmacokinetics of AV650
A Phase 1 Double-Blind, Placebo-Controlled Single Center Trial to Assess the Safety, Tolerability and Pharmacokinetics of Single Dose and Multiple Dose Escalations of AV650 in Healthy Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 30 (planned)
- Sponsor
- Avigen · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to determine the safety and tolerability of AV650 in healthy subjects given single and multi-doses under fasted and fed conditions.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | AV650 |
Timeline
- Start date
- 2006-08-01
- First posted
- 2006-08-15
- Last updated
- 2007-02-28
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00364039. Inclusion in this directory is not an endorsement.